Stay updated on FRα Clinical Trial: Mirvetuximab vs. Chemo
Sign up to get notified when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.

Latest updates to the FRα Clinical Trial: Mirvetuximab vs. Chemo page
- CheckyesterdayChange DetectedThe site’s displayed revision changes from v3.7.0 to v3.7.1, while the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the detailed study record content with a minimal error screen.SummaryDifference18%

- Check43 days agoChange DetectedThe page now shows a revised version tag updating from v3.6.5 to v3.6.6, reflecting a small internal update rather than any change to study content.SummaryDifference0.0%

- Check57 days agoChange DetectedThe Study Details page now includes a Study Documents section with PDF links for the Study Protocol and Statistical Analysis Plan and related MeSH terms, expanding access to the study’s documentation and terminology. This change replaces the prior error content, restoring full resources on the page.SummaryDifference100%

- Check64 days agoChange DetectedThe page now shows a new revision tag (v3.6.5) replacing the previous v3.6.4, indicating a minor update to the page. This update does not alter the study details or results.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision: v3.6.4 replaces the previous v3.6.3 as part of a minor platform update. This change updates the page's version tag but does not alter study content, eligibility criteria, or results.SummaryDifference0.0%

Stay in the know with updates to FRα Clinical Trial: Mirvetuximab vs. Chemo
Enter your email address, and we'll notify you when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.